Nyuma ya GLP-1, niki gikurikira cyo kugabanya ibiro?

GLP-1 agonist Wegovy yongeye guha ingufu guhiga kuvura umubyibuho ukabije. Ubundi buryo -kuvana muburyohe busharira kugeza imitsi ya bagiteri na bagiteri - bimaze kuba mumavuriro.

Semaglutide ni glucagon isa na peptide-1 (GLP-1) reseptor agonist ikoreshwa mu kuvura abantu bakuru barwaye diyabete yo mu bwoko bwa 2. Ifasha kugenzura urugero rw'isukari mu maraso itera insuline irekura, kugabanya glucagon irekura, no gutinda gusohora gastric. Byongeye kandi, dosiye yo hasi ya semaglutide iherutse gukorwa kugirango ivure umubyibuho ukabije. Gukoresha semaglutide bisaba kwandikirwa kwa muganga no kuyobora.

Iyi nyongera irazwi cyane ku isoko ku buryo abantu benshi bemeza inyungu zayo zo kugabanya ibiro ku buryo rwiyemezamirimo w’umuherwe Elon Musk yanditse ku rubuga rwa Twitter mu Kwakira 2022 ko yakoresheje Semaglutide mu guhindura ibiro. Ku ya 1 Ukwakira, umufana yashyizeho ifoto ye amubaza icyo "ibanga" rye ari ugutakaza ibiro. Musk aramusubiza ati: "Kwiyiriza ubusa, mbere yo kongeraho ati:" Na Wegovy. "

By'umwihariko, Semaglutide irashobora kugabanya ibiro muburyo bukurikira:

Kurwanya ubushake bwo kurya: Semaglutide irashobora gukora binyuze muri sisitemu yo hagati yo guhagarika ubushake bwo kurya no kugabanya ibiryo byinjiye.

Guteza imbere gutwika amavuta: Semiglutide irashobora kongera gusenyuka no gukoresha ibinure, guteza imbere gutwika amavuta, bityo bikagabanya kwirundanya kw'amavuta.

Kugenzura urugero rw'isukari mu maraso: Semaglutide irashobora kugabanya urugero rw'isukari mu maraso kandi ikarinda isukari yo mu maraso kuba hejuru cyangwa hasi cyane, bityo bikagabanya synthesis hamwe no kwirundanya.